how are people getting retatrutide Retatrutide: A Promising Option for Non-Diabetic Weight Loss in Clinical Trials Retatrutide Weight Loss Treatment Explained

Administered either SQ or IM

Rheumatology 61 , 45214534 (2022)

A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes

Convenient home delivery for hassle-free treatment

[14] [15] Routine follow-up appointments are essential for monitoring therapeutic response and adjusting treatment

These medications are the go-to medications for most endocrinologists and other thyroid doctors